A psychedelic nasal spray requiring a much shorter period of clinical supervision has shown promise against ...

As respiratory illnesses like COVID-19, influenza, and Mycoplasma pneumonia continue to spread, the need for safe, ...

Lupin launches Ipratropium Bromide Nasal Solution in the US market; eyes expanding complex generics pipeline to over 200 ...

Mumbai: Global pharma major Lupin Limited has launched Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06%, in ...

BPL-003 showed “robust” efficacy data in treatment-resistant depression, according to analysts from Jefferies, who noted that ...

A nasal spray for treatment-resistant depression has delivered strong clinical results and rekindled investor hopes.

MONTREAL and CHARLOTTE, N.C., June 16, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced submission of its response to the U.S. Food and Drug Administration ...

A new study found that almost all plans in 40 states and Washington, DC covered at least one form of the opioid overdose ...

ARS Pharma has claimed FDA approval for its epinephrine nasal spray neffy, becoming the first needle-free alternative to EpiPen-style autoinjectors for serious allergic reactions. The green light ...

Detailed price information for Milestone Pharmaceuticals Inc (MIST-Q) from The Globe and Mail including charting and trades.

An alternative to epinephrine autoinjectors that can be delivered by a nasal spray has been launched in Germany, its first ...

Positive study results in Phase 2 lead to a green light for the companies’ combination and plans to move their nasal spray ...